Outcomes in a Multi-institutional Cohort of Patients Treated With Intraoperative Radiation Therapy for Advanced or Recurrent Renal Cell Carcinoma
Jonathan J. Paly(Harvard University), Jason A. Efstathiou(Massachusetts General Hospital), Peter J. Biggs(Massachusetts General Hospital), Andrzej Niemierko(Harvard University), Richard Choo(Mayo Clinic), Felipe A. Calvo(Hospital General Universitario Gregorio Marañón), Falk Roeder(Heidelberg University), Christopher L. Hallemeier(Mayo Clinic in Arizona), Gerd Fastner(Dana-Farber Cancer Institute), Felix Sedlmayer, Anthony L. Zietman(Harvard University), Michael G. Haddock(Mayo Clinic in Arizona), Jared M. Whitson(University of California, San Francisco), Rodney J. Ellis(Pennsylvania State University), William U. Shipley(Massachusetts General Hospital), William W. Wong(Mayo Clinic in Arizona), Rafael Martínez‐Monge(Navarre Institute of Health Research)
International Journal of Radiation Oncology*Biology*Physics
January 8, 2014
Cited by 35
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k